The US Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the treatment of adults with ALK-positive locally advanced or...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until...